1. Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1

   • Miyuki Harada
   • Fuminori Kimura
   • Nao Suzuki

   Special Article Open access 01 January 2022 Pages: 265 - 280

2. Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2

   • Akiko Tozawa
   • Fuminori Kimura
   • Yutaka Osuga

   Special Article Open access 13 January 2022 Pages: 281 - 300

   

3. Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases

   • Masanori Ono
   • Kimikazu Matsumoto
   • Nao Suzuki

   Invited Review Article Open access 17 November 2021 Pages: 301 - 309

   

4. Treatments for elderly cancer patients and reforms to social security systems in Japan

   • Fumio Nagashima
   • Junji Furuse

   Invited Review Article 31 January 2022 Pages: 310 - 315

5. Aging, cancer, and antitumor immunity

   • Hideki Ikeda
   • Yosuke Togashi

   Invited Review Article 30 March 2021 Pages: 316 - 322

   

6. High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile

   • Tavonna D. Kako
   • Maahum Z. Kamal
   • Rebecca C. Arend

   Review Article 17 January 2022 Pages: 323 - 331

   

7. HER2-low breast cancer could be associated with an increased risk of brain metastasis

   • Deniz Can Guven
   • Mehmet Burak Kaya
   • Sercan Aksoy

   Original Article 18 October 2021 Pages: 332 - 339

   

8. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis

   • Wei-xiang Qi
   • Chunrong Chen
   • Jiayi Chen

   Original Article 03 November 2021 Pages: 340 - 347

   

9. Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer

   • Masaya Takahashi
   • Katsuyuki Takahashi
   • Katsuya Nagayama

   Original Article 22 October 2021 Pages: 348 - 353

   

10. Hsa_circ_0003195 as a biomarker for diagnosis and prognosis of gastric cancer

    • Yibo Ma
    • Zhe Li
    • Weiliang Sun

    Original Article 13 November 2021 Pages: 354 - 361

    

11. Systematic study on expression and prognosis of E2Fs in human colorectal cancer

    • Yating Ma
    • Shijian Wang
    • Chengbin Wang

    Original Article 18 October 2021 Pages: 362 - 372

    

12. Estimated tumor blood flow as a predictive imaging indicator of therapeutic response in pancreatic ductal adenocarcinoma: use of three-phase contrast-enhanced computed tomography

    • Hiromitsu Maehira
    • Yoshihisa Tsuji
    • Masaji Tani

    Original Article 16 November 2021 Pages: 373 - 382

    

13. Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis

    • Yoshihiko Tomita
    • Yoshiaki Yamamoto
    • Hirotsugu Uemura

    Original Article Open access 01 January 2022 Pages: 383 - 395

    

14. The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy

    • Koki Obayashi
    • Jun Miki
    • Shin Egawa

    Original Article 29 October 2021 Pages: 396 - 402

    

15. Overweight and obesity as risk factors for biochemical recurrence of prostate cancer after radical prostatectomy

    • Sung Jin Kim
    • Min Uk Park
    • Jong Yeon Park

    Original Article 29 October 2021 Pages: 403 - 410

    

16. Prognostic value of PSA bounce after definitive radiotherapy revisited

    • Fumihiko Urabe
    • Takahiro Kimura
    • Shin Egawa

    Original Article 22 October 2021 Pages: 411 - 417

    

17. Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan

    • Akira Yokomizo
    • Junji Yonese
    • Norio Nonomura

    Original Article Open access 15 November 2021 Pages: 418 - 426

    

18. Lower accuracy of cytological screening for high-grade squamous intraepithelial neoplasia in women over 50 years of age in Japan

    • Michiyasu Miki
    • Yoshihiro Imaeda
    • Takuma Fujii

    Original Article Open access 06 December 2021 Pages: 427 - 433

    

19. Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer

    • Michiko Wada
    • Ken Yamaguchi
    • Noriko Satoh-Asahara

    Original Article Open access 30 October 2021 Pages: 434 - 440

    

20. Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients

    • Naomi Iwasa-Inoue
    • Hiroyuki Nomura
    • Daisuke Aoki

    Original Article 14 October 2021 Pages: 441 - 447

21. COVID-19 infection in pediatric patients treated for cancer

    • Lital Oz-Alcalay
    • Sarah Elitzur
    • Oded Gilad

    Original Article 06 November 2021 Pages: 448 - 454

    

22. Correction to: COVID‑19 infection in pediatric patients treated for cancer

    • Lital Oz-Alcalay
    • Sarah Elitzur
    • Oded Gilad

    Correction 04 December 2021 Pages: 455 - 455

23. Correction to: APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients

    • Misato Takao
    • Tatsuro Yamaguchi
    • Hideyuki Ishida

    Correction 20 December 2021 Pages: 456 - 456